Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HV.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDRNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.43.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDPNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.20.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.110NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.8.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.89NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.105NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used